Xencor Inc (XNCR) is a pharmaceutical preparations company. Piotroski F-Score 3/8. 13 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-05 from XNCR's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on XNCR plus an auto-SWOT — built from XNCR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate XNCR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Feigal EllenDirector | SELL | $89K | view → |
| Montgomery Alan BruceDirector | SELL | $62K | view → |
| RANIERI RICHARD JDirector | SELL | $67K | view → |
| GUSTAFSON KURT ADirector | SELL | $67K | view → |
| GORMAN KEVIN CHARLESDirector | SELL | $93K | view → |
| Cornelissen Bart JanSR. VICE PRESIDENT & CFO | SELL | $43K | view → |
| Dahiyat Bassil IPRESIDENT & CEO | SELL | $240K | view → |
| Cornelissen Bart JanSR. VICE PRESIDENT & CFO | SELL | $28K | view → |
Projected from XNCR's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment XNCR files its announcement.
XNCR's earnings reaction has been evenly split — 4 up, 4 down across its last 8 reports.
Large earnings reactions have been common.
The average is inflated by its most volatile prints (+14.7% and -7.9%).
A more typical earnings reaction has been approximately ±7.0%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-06 | -4.2% |
| 2026-02-25 | +14.7% |
| 2026-01-08 | -7.1% |
| 2025-11-05 | +2.2% |
| 2025-08-06 | -7.9% |
| 2025-05-07 | +3.9% |
| 2025-02-27 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +6.8% |
| 2025-01-13 | -7.3% |